Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers

Mostrar otras versiones (1)

Accurate serological assays to detect antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed to characterize the epidemiology of SARS-CoV-2 infection and identify potential candidates for coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) donation. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Eshan U., Bloch, Evan M., Clarke, William, Hsieh, Yu-Hsiang, Boon, Denali, Eby, Yolanda, Fernandez, Reinaldo E., Baker, Owen R., Keruly, Morgan, Kirby, Charles S., Klock, Ethan, Littlefield, Kirsten, Miller, Jernelle, Schmidt, Haley A., Sullivan, Philip, Piwowar-Manning, Estelle, Shrestha, Ruchee, Redd, Andrew D., Rothman, Richard E., Sullivan, David, Shoham, Shmuel, Casadevall, Arturo, Quinn, Thomas C., Pekosz, Andrew, Tobian, Aaron A. R., Laeyendecker, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111143/
https://www.ncbi.nlm.nih.gov/pubmed/33139419
http://dx.doi.org/10.1128/JCM.02257-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111143/
https://www.ncbi.nlm.nih.gov/pubmed/33139419
http://dx.doi.org/10.1128/JCM.02257-20

Ejemplares similares